Skip to main content
Erschienen in: International Urogynecology Journal 7/2018

25.01.2018 | Original Article

Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder

verfasst von: Akira Furuta, Tokunori Yamamoto, Yasuyuki Suzuki, Momokazu Gotoh, Shin Egawa, Naoki Yoshimura

Erschienen in: International Urogynecology Journal | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Chronic inflammatory conditions seem to be a shared characteristic in patients with interstitial cystitis (IC) and overactive bladder (OAB). Thus, we measured 40 inflammatory urine markers in IC patients with or without Hunner’s lesions (HIC and NHIC respectively) and OAB patients.

Methods

Urine was collected from consecutive HIC patients, NHIC patients, and age and gender-matched OAB patients with no history of IC, recurrent urinary tract infection or bladder cancer. The diagnosis of IC was based on the Asian IC guideline criteria. A representative 40 inflammatory growth factors, cytokines, and chemokines in urine were measured using a MILLIPLEX immunoassay kit. Statistical differences in these markers among the groups were determined by nonparametric ANOVA followed by multiple comparison test. The diagnostic efficiency of these markers was measured using receiver operating characteristic analysis.

Results

Vascular endothelial growth factor (VEGF), interleukin-1α (IL-1α), IL-6, and chemokines including CCL2, CCL5, CXCL1, CXCL8, and CXCL10 were significantly increased in HIC (n = 30) and NHIC (n = 30) patients compared with OAB (n = 28) patients. The significant increases in CXCL8 and CXCL10 were also found in HIC patients compared with NHIC patients. However, there were no significant differences in the other urine markers among the groups. Area under the curves for VEGF, CXCL10, CXCL8, IL-1α, CCL5, CCL2, IL-6, and CXCL1 to detect IC in these patients were 0.87, 0.86, 0.81, 0.80, 0.80, 0.71, 0.66, and 0.50 respectively.

Conclusions

The increases in angiogenesis-associated proteins such as VEGF and CXCL10 may be pathophysiologically important for the development of IC.
Literatur
1.
Zurück zum Zitat Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol. 2016;23(7):542–9.CrossRefPubMed Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol. 2016;23(7):542–9.CrossRefPubMed
2.
Zurück zum Zitat Van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7.CrossRefPubMed Van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7.CrossRefPubMed
3.
Zurück zum Zitat Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249–57.CrossRefPubMed Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249–57.CrossRefPubMed
4.
Zurück zum Zitat Chidlow JH, Shukla D, Grisham MB, Kevil CG. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol. 2007;293(1):5–18.CrossRef Chidlow JH, Shukla D, Grisham MB, Kevil CG. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol. 2007;293(1):5–18.CrossRef
5.
Zurück zum Zitat Ammit AJ, Lazaar AL, Irani C, O’Neill GM, Gordon ND, et al. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol. 2002;26(4):465–74.CrossRefPubMed Ammit AJ, Lazaar AL, Irani C, O’Neill GM, Gordon ND, et al. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol. 2002;26(4):465–74.CrossRefPubMed
6.
Zurück zum Zitat Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P. Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha. Urology. 2006;67(1):214–9.CrossRefPubMed Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P. Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha. Urology. 2006;67(1):214–9.CrossRefPubMed
7.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78.CrossRefPubMed Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78.CrossRefPubMed
8.
Zurück zum Zitat Bo K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213.CrossRefPubMed Bo K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213.CrossRefPubMed
9.
Zurück zum Zitat Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, et al. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type a for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol. 2008;53(6):1245–53.CrossRefPubMed Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, et al. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type a for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol. 2008;53(6):1245–53.CrossRefPubMed
10.
Zurück zum Zitat Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, et al. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol. 2010;42(3):629–35.CrossRefPubMed Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, et al. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol. 2010;42(3):629–35.CrossRefPubMed
11.
Zurück zum Zitat Torimoto K, Matsushita C, Yamada A, Goto D, Matsumoto Y, et al. Clinical efficacy and safety of mirabegron and imidafenacin in women with overactive bladder: a randomized crossover study (the MICRO study). Neurourol Urodyn. 2017;36(4):1097–103.CrossRefPubMed Torimoto K, Matsushita C, Yamada A, Goto D, Matsumoto Y, et al. Clinical efficacy and safety of mirabegron and imidafenacin in women with overactive bladder: a randomized crossover study (the MICRO study). Neurourol Urodyn. 2017;36(4):1097–103.CrossRefPubMed
12.
Zurück zum Zitat Gamper M, Viereck V, Eberhard J, Binder J, Moll C, et al. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C. Int Urogynecol J. 2013;24(12):2049–57.CrossRefPubMedPubMedCentral Gamper M, Viereck V, Eberhard J, Binder J, Moll C, et al. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C. Int Urogynecol J. 2013;24(12):2049–57.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Crosley LK, Duthie SJ, Polley AC, Bouwman FG, Heim C, et al. Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics. Genes Nutr. 2009;4(2):95–102.CrossRefPubMedPubMedCentral Crosley LK, Duthie SJ, Polley AC, Bouwman FG, Heim C, et al. Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics. Genes Nutr. 2009;4(2):95–102.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tyagi P, Killinger K, Tyagi V, Nirmal J, Chancellor M, et al. Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis. J Urol. 2012;187(6):2243–8.CrossRefPubMedPubMedCentral Tyagi P, Killinger K, Tyagi V, Nirmal J, Chancellor M, et al. Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis. J Urol. 2012;187(6):2243–8.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kiuchi H, Tsujimura A, Takao T, Yamamoto K, Nakayama J, et al. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations. BJU Int. 2009;104(6):826–31; discussion 31CrossRefPubMed Kiuchi H, Tsujimura A, Takao T, Yamamoto K, Nakayama J, et al. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations. BJU Int. 2009;104(6):826–31; discussion 31CrossRefPubMed
16.
Zurück zum Zitat Lee JD, Lee MH. Increased expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor associated with glomerulation formation in patients with interstitial cystitis. Urology. 2011;78(4):971. e11–5CrossRefPubMed Lee JD, Lee MH. Increased expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor associated with glomerulation formation in patients with interstitial cystitis. Urology. 2011;78(4):971. e11–5CrossRefPubMed
17.
Zurück zum Zitat Lazarus A, Keshet E. Vascular endothelial growth factor and vascular homeostasis. Proc Am Thorac Soc. 2011;8(6):508–11.CrossRefPubMed Lazarus A, Keshet E. Vascular endothelial growth factor and vascular homeostasis. Proc Am Thorac Soc. 2011;8(6):508–11.CrossRefPubMed
18.
Zurück zum Zitat Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun. 1995;210(1):51–7.CrossRefPubMed Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun. 1995;210(1):51–7.CrossRefPubMed
19.
Zurück zum Zitat Luster AD, Cardiff RD, MacLean JA, Crowe K, Granstein RD. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians. 1998;110(3):183–96.PubMed Luster AD, Cardiff RD, MacLean JA, Crowe K, Granstein RD. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians. 1998;110(3):183–96.PubMed
20.
Zurück zum Zitat Bouchelouche K, Alvarez S, Andersen L, Nordling J, Horn T, et al. Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells. J Urol. 2004;171(1):462–6.CrossRefPubMed Bouchelouche K, Alvarez S, Andersen L, Nordling J, Horn T, et al. Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells. J Urol. 2004;171(1):462–6.CrossRefPubMed
21.
Zurück zum Zitat Tyagi P, Tyagi V, Qu X, Chuang YC, Kuo HC, et al. Elevated CXC chemokines in urine noninvasively discriminate OAB from UTI. Am J Physiol Ren Physiol. 2016;311(3):F548–54.CrossRef Tyagi P, Tyagi V, Qu X, Chuang YC, Kuo HC, et al. Elevated CXC chemokines in urine noninvasively discriminate OAB from UTI. Am J Physiol Ren Physiol. 2016;311(3):F548–54.CrossRef
22.
Zurück zum Zitat Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, et al. A comparison of multiple urine markers for interstitial cystitis. J Urol. 2002;167(6):2461–9.CrossRefPubMed Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, et al. A comparison of multiple urine markers for interstitial cystitis. J Urol. 2002;167(6):2461–9.CrossRefPubMed
23.
Zurück zum Zitat Maeda D, Akiyama Y, Morikawa T, Kunita A, Ota Y, et al. Hunner-type (classic) interstitial cystitis: a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation. PLoS One. 2015;10(11):e0143316.CrossRefPubMedPubMedCentral Maeda D, Akiyama Y, Morikawa T, Kunita A, Ota Y, et al. Hunner-type (classic) interstitial cystitis: a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation. PLoS One. 2015;10(11):e0143316.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, et al. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008;179(5):1850–6.CrossRefPubMedPubMedCentral Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, et al. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008;179(5):1850–6.CrossRefPubMedPubMedCentral
Metadaten
Titel
Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder
verfasst von
Akira Furuta
Tokunori Yamamoto
Yasuyuki Suzuki
Momokazu Gotoh
Shin Egawa
Naoki Yoshimura
Publikationsdatum
25.01.2018
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 7/2018
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-017-3547-5

Weitere Artikel der Ausgabe 7/2018

International Urogynecology Journal 7/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.